COVID-19 Blog - Microbix

Microbix & Seegene USA Jointly Enhancing Lab Test Accuracy

Dec 14, 2023

Expanded Collaboration to Improve Syndromic Infectious Disease Testing MISSISSAUGA, CANADA & IRVINE, CALIFORNIA, December 14, 2023 –...

Dec 7, 2023

Quality Controls for Respiratory Viral, Pharyngitis, and Genital Ulcer Disease Panels MISSISSAUGA, CANADA & BIRMINGHAM, ALABAMA,...

Dec 6, 2023

For Repurchase of up to 5% of its outstanding shares over 12 months MISSISSAUGA, CANADA, December 6, 2023 - Microbix Biosystems Inc. (TSX:...

Nov 17, 2023

Meetings with Growth-Oriented Investors, November 17 to 19, 2023 MISSISSAUGA, CANADA, November 17, 2023 - Microbix Biosystems Inc. (TSX:...

Nov 16, 2023

Sequel Pharma Reconfirms Kinlytic® urokinase Support for Catheter Clearance Indication MISSISSAUGA, CANADA, November 16, 2023 – Microbix...

Nov 10, 2023

Onboarding Tools and Quality Controls for Extended Genotype HPV Assays MISSISSAUGA, CANADA & TRIESTE, ITALY, November 10, 2023 –...

Nov 8, 2023

Flu season is upon us, and with it comes the annual threat of influenza, respiratory syncytial virus (RSV), and more recently, the...

Oct 27, 2023

Distribution Partner Secures Contract Relating to Cervical Cancer Screening MISSISSAUGA, CANADA, October 27, 2023 – Microbix Biosystems...

Oct 26, 2023

In this episode of Diagnostics: Beyond the Lab we talk to two very distinguished guests, Christine Elliott, who served as the deputy...

Oct 20, 2023